Transce3nd’s HCA Healthcare HCA Stock Holding History

Transce3nd’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22	Closed	-$8.43K	–	579
2025 Q2	$8.43K	Buy	22 +4	+22%	+$1.44K	﹤0.01%	617
2025 Q1	$6.22K	Buy	18 +6	+50%	+$1.93K	﹤0.01%	674
2024 Q4	$3.6K	Buy	+12	New	+$4.19K	﹤0.01%	1000

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Transce3nd's HCA Position: Q3 2025 in Review

Transce3nd sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 22 shares — an estimated $8.43K sold.

Transce3nd first reported a position in HCA in Q4 2024 and held it in 3 quarters. The position peaked at $8.43K in Q2 2025. 1,289 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

Transce3nd reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 22 HCA Healthcare shares in Q3 2025, an estimated $8.43K.
Transce3nd first reported a position in HCA Healthcare in Q4 2024 and held it in 3 quarters.
Transce3nd's HCA Healthcare position peaked at $8.43K in Q2 2025.
1,289 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.